HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Kaposi Sarcoma is a rare form of cancer that originates in the cells lining blood vessels or lymphatic vessels. It is often linked to infection with human herpesvirus 8 (HHV-8), particularly in individuals with weakened immune systems, such as those with HIV/AIDS. This cancer typically presents as lesions on the skin, mucous membranes, or internal organs. The skin lesions often appear as red, purple, or brown patches or nodules. In some cases, Kaposi Sarcoma can involve the gastrointestinal tract, respiratory system, and other internal organs, leading to more severe complications. The prevalence of Kaposi Sarcoma has significantly decreased with the advent of effective antiretroviral therapy for HIV/AIDS, as the immune system is better able to control HHV-8 infection. However, the disease may still occur in individuals with compromised immune function. Treatment approaches for Kaposi Sarcoma depend on the extent of the disease and the overall health of the patient. Therapeutic options may include surgery, radiation therapy, chemotherapy, or immunotherapy. Management often requires a multidisciplinary approach involving oncologists, infectious disease specialists, and other healthcare professionals. Regular medical check-ups and monitoring are crucial for individuals at risk, particularly those with HIV/AIDS. Early detection and intervention can improve the prognosis and quality of life for individuals affected by Kaposi Sarcoma. It is essential for healthcare providers and patients alike to remain vigilant in addressing this unique cancer and its associated risk factors.
